Thank you... this is truly the first independent a
Post# of 148165
(Total Views: 565)
Posted On: 04/02/2020 12:26:32 AM
Thank you... this is truly the first independent article I've seen to date (besides video interviews). All other media outlets are just repeating what's been in the Press Releases coming out from CytoDyn via its PR firm RedChip Companies.
I see that Ed Walsh is a regular reporter at the Bay Area Reporter (local newspaper) but also been a patient of Dr. Lalezari in the Pro-140 HIV study. So maybe that's why this interview was granted to a publication. It's a terrific article as it explains many complex subjects in layman terms and covers a lot of ground.. a good read. And great to see how physicians can get Leronlimab:
This is the kind of story that should be in a lot of newspapers throughout the country right now.
What's equally great and important is to have those video interviews like the 3/20/20 one because company officials for almost 45-minutes are addressing specific questions. It's this interview where Dr. Pourhassan states they're testing 12-14 women with breast cancer. It has a lot of info on utilization and production of Leronlimab and the COVID-19 trial as it started. And btw Dr. Pourhassan was spot on in terms of timing of proceeding with the CoronaVirus trial. He also speaks to uplifting to either the Nasdaq or NYSE.
I see that Ed Walsh is a regular reporter at the Bay Area Reporter (local newspaper) but also been a patient of Dr. Lalezari in the Pro-140 HIV study. So maybe that's why this interview was granted to a publication. It's a terrific article as it explains many complex subjects in layman terms and covers a lot of ground.. a good read. And great to see how physicians can get Leronlimab:
Quote:
Lalezari said that doctors treating COVID-19 patients can request the use of Leronlimab by applying to the U.S. Food and Drug Administration for its EMERGENCY use as treatment for COVID-19.
This is the kind of story that should be in a lot of newspapers throughout the country right now.
What's equally great and important is to have those video interviews like the 3/20/20 one because company officials for almost 45-minutes are addressing specific questions. It's this interview where Dr. Pourhassan states they're testing 12-14 women with breast cancer. It has a lot of info on utilization and production of Leronlimab and the COVID-19 trial as it started. And btw Dr. Pourhassan was spot on in terms of timing of proceeding with the CoronaVirus trial. He also speaks to uplifting to either the Nasdaq or NYSE.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼